It has been hypothesized that chemoattractant factors, released during radiotherapy by tumor cells, including granulocyte-macrophage colony stimulating factor (GM-CSF) [63], IL-6, or IL-8 [64], promote CTC recruitment back to the primary tumor site. Here, CSF2 is linked to neoplasm.